When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Wiskott-Aldrich syndrome

Última revisión: 10 Feb 2026
Última actualización: 10 Jan 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • family history of WAS
  • easy bruising and petechiae
Todos los datos

Otros factores de diagnóstico

  • recurrent infections
  • eczema
  • bruises and petechiae
  • lymphadenopathy
  • perforated tympanic membranes
  • serious bleeding
  • serious/life-threatening infection
  • autoimmunity
Todos los datos

Factores de riesgo

  • maternal WAS gene mutation carrier
  • male sex
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • CBC with platelet volume
  • WAS protein (WASp) analysis
  • WAS protein (WASp) gene mutation analysis
Todos los datos

Pruebas diagnósticas que deben considerarse

  • immunoglobulin levels
  • vaccine responses
  • isohemagglutinins
  • lymphocyte subsets
  • T-cell proliferation assays
  • liver function tests
  • polymerase chain reaction analysis for hepatitis C
  • polymerase chain reaction tests for adenovirus, Epstein-Barr virus, and cytomegalovirus
  • store serum and plasma
Todos los datos

Algoritmo de tratamiento

En curso

attenuated WAS

severe, classical WAS

Colaboradores

Autores

Siobhan Burns, MB BAO BCh, MRCPI (Paeds)
Siobhan Burns

Reader and Consultant in Immunology

University College London

Department of Immunology

Royal Free Hospital

London

UK

Divulgaciones

SB has received travel expenses for educational conferences from Baxalta US Inc. and CSL Behring. SB has received a consulting fee from CSL Behring for a talk given about the use of subcutaneous immunoglobulin. SB has received grant funding for research into immunoglobulin treatment for primary immunodeficiency from CSL Behring. SB is the author of articles cited in this topic.

Adrian Thrasher, PhD, MD, BS, FRCP, MRCPCH, FMedSci
Adrian Thrasher

Professor of Paediatric Immunology

Molecular Immunology Unit and Centre for Immunodeficiency

Institute of Child Health

University College London

London

UK

Divulgaciones

AT has done consultancy work for Orchard Therapeutics and Autolus, and owns stock in both. AT was an expert witness for Ward Hadaway Solicitors for a case of Wiskott-Aldrich syndrome. He is an author of references cited in this topic.

Revisores por pares

Phil Fischer, MD

Professor of Pediatrics

Mayo Clinic

Rochester

MN

Divulgaciones

PF declares that he has no competing interests.

Deepak Kamat, MD, PhD

Professor of Pediatrics

Wayne State University

Vice Chair of Education

Director

Institute of Medical Education

The Carman and Ann Adams Department of Pediatrics

Children's Hospital of Michigan

Detroit

MI

Divulgaciones

DK declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

O'Sullivan E, Kinnon C, Brickell P. Wiskott-Aldrich syndrome protein, WASP. Int J Biochem Cell Biol. 1999;31:383-387. Resumen

Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456-464.Texto completo  Resumen

Burns S, Cory GO, Vainchenker W, et al. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood. 2004;104:3454-3462.Texto completo  Resumen

Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001;97:1598-1603.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Wiskott-Aldrich syndrome images
  • Diferenciales

    • Idiopathic thrombocytopenia (ITP)
    • Autoimmune lymphoproliferative syndrome (ALPS)
    Más Diferenciales
  • Guías de práctica clínica

    • COVID-19 vaccines for moderately or severely immunocompromised people
    • EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity
    Más Guías de práctica clínica
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad